PL1890994T3 - Stabilny kompleks substancji czynnej soli kwasu O-acetylosalicylowego z aminokwasami zasadowymi i glicyną - Google Patents

Stabilny kompleks substancji czynnej soli kwasu O-acetylosalicylowego z aminokwasami zasadowymi i glicyną

Info

Publication number
PL1890994T3
PL1890994T3 PL06743005T PL06743005T PL1890994T3 PL 1890994 T3 PL1890994 T3 PL 1890994T3 PL 06743005 T PL06743005 T PL 06743005T PL 06743005 T PL06743005 T PL 06743005T PL 1890994 T3 PL1890994 T3 PL 1890994T3
Authority
PL
Poland
Prior art keywords
stabile
glycine
salts
amino acids
active ingredient
Prior art date
Application number
PL06743005T
Other languages
English (en)
Inventor
Gerhard Franckowiak
Wolfram Ledwoch
Eberhard Schweinheim
Yutaka Hayauchi
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36649662&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1890994(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of PL1890994T3 publication Critical patent/PL1890994T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38—Separation; Purification; Stabilisation; Use of additives
    • C07C227/40—Separation; Purification
    • C07C227/42—Crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12—Acetic acid esters
    • C07C69/14—Acetic acid esters of monohydroxylic compounds
    • C07C69/145—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols
    • C07C69/157—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL06743005T 2005-06-02 2006-05-20 Stabilny kompleks substancji czynnej soli kwasu O-acetylosalicylowego z aminokwasami zasadowymi i glicyną PL1890994T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005025283A DE102005025283A1 (de) 2005-06-02 2005-06-02 Stabiler Wirkstoffkomplex von Salzen der o-Acetylsalicylsäure mit basischen Aminosäuren und Glycin
EP06743005A EP1890994B1 (de) 2005-06-02 2006-05-20 Stabiler wirkstoffkomplex von salzen der o-acetylsalicylsäure mit basischen aminosäuren und glycin
PCT/EP2006/004799 WO2006128600A2 (de) 2005-06-02 2006-05-20 Stabiler wirkstoffkomplex von salzen der o-acetylsalicylsäure mit basischen aminosäuren und glycin

Publications (1)

Publication Number Publication Date
PL1890994T3 true PL1890994T3 (pl) 2012-03-30

Family

ID=36649662

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06743005T PL1890994T3 (pl) 2005-06-02 2006-05-20 Stabilny kompleks substancji czynnej soli kwasu O-acetylosalicylowego z aminokwasami zasadowymi i glicyną

Country Status (32)

Country Link
US (1) US8063243B2 (pl)
EP (1) EP1890994B1 (pl)
JP (1) JP2008542316A (pl)
KR (1) KR101347522B1 (pl)
CN (1) CN101248036B (pl)
AR (1) AR057341A1 (pl)
AT (1) ATE526974T1 (pl)
AU (1) AU2006254429B2 (pl)
BR (1) BRPI0610734A2 (pl)
CA (1) CA2610194C (pl)
CR (1) CR9556A (pl)
CY (1) CY1112185T1 (pl)
DE (1) DE102005025283A1 (pl)
DK (1) DK1890994T3 (pl)
ES (1) ES2373917T3 (pl)
HR (1) HRP20120003T1 (pl)
IL (1) IL187772A (pl)
MA (1) MA29604B1 (pl)
MX (1) MX2007014988A (pl)
NO (1) NO20076592L (pl)
NZ (1) NZ563871A (pl)
PL (1) PL1890994T3 (pl)
PT (1) PT1890994E (pl)
RS (1) RS52111B (pl)
RU (1) RU2433995C2 (pl)
SG (1) SG162744A1 (pl)
SI (1) SI1890994T1 (pl)
TN (1) TNSN07452A1 (pl)
TW (1) TWI374740B (pl)
UA (1) UA89827C2 (pl)
WO (1) WO2006128600A2 (pl)
ZA (1) ZA200710251B (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008004386A1 (de) * 2008-01-14 2009-07-23 Activaero Gmbh Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen
BRPI1009600A2 (pl) * 2009-06-25 2016-03-22 Tetra S A
AU2010263409B2 (en) * 2009-06-25 2013-09-05 Tetra, Sia Novel acetylsalicylic acid salts
FR2950625B1 (fr) * 2009-09-30 2016-12-02 Holis Tech Procede de preparation d'un sel d'acide o-acetylsalicylique d'un acide amine basique et composition obtenue
FR2965261B1 (fr) * 2009-09-30 2012-10-26 Holis Technologies Procede de preparation d'un sel d'acide o-acetylsalicylique d'un acide amine basique et composition obtenue par ce procede
TWI478715B (zh) * 2010-12-03 2015-04-01 Tetra Sia 新穎乙醯柳酸鹽
RU2011132483A (ru) * 2011-08-02 2013-02-10 Елена Александровна Моренко Биологически активный продукт для применения в ветеринарии и животноводстве, способ его получения и способы повышения выживаемости, стимуляции роста, иммуностимуляции и повышения общей неспецифической резистентности организма сельскохозяйственных животных
CN102503845A (zh) * 2011-09-28 2012-06-20 广州普星药业有限公司 一种dl-赖氨酸阿司匹林盐的制备方法及其应用
ITMI20121144A1 (it) * 2012-06-28 2013-12-29 Dipharma Francis Srl Procedimento per la preparazione di un sale di un farmaco antinfiammatorio non steroideo
LV14963B (lv) 2013-06-28 2015-10-20 Tetra, Sia Endoteliālās disfunkcijas korektors
JP7137479B2 (ja) * 2016-02-23 2022-09-14 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング グリシン粒子
AU2017383071B2 (en) 2016-12-23 2021-04-29 Aspiair Gmbh Improved synthesis of lysine acetylsalicylate · glycine particles
CN110996965A (zh) 2017-05-30 2020-04-10 罗山制药股份有限公司 稳定、无菌和结晶的邻乙酰水杨酸(阿司匹林)的小瓶内沉积物
CN112592286B (zh) * 2020-11-23 2024-02-02 蚌埠丰原医药科技发展有限公司 一种阿司匹林与碱性氨基酸的络合物的制备方法
CA3239851A1 (en) 2022-01-05 2023-07-13 Karlheinz Nocker Improved synthesis of lysine acetylsalicylate · glycine particles

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5610110A (en) * 1979-07-06 1981-02-02 Green Cross Corp:The Acetyl salicylate salt preparation for injection
JPS5665816A (en) * 1979-11-01 1981-06-03 Green Cross Corp:The Acetylsalicylate pharmaceutical for injection
US4446132A (en) * 1982-03-11 1984-05-01 Dynatech Laboratories Incorporated Nontoxic aspirin composition
CS247688B1 (cs) * 1984-12-22 1987-01-15 Evzen Kasafirek Způsob výroby soli lysinu s kyselinou acetylsalicylovou
EP0499142A3 (en) * 1991-02-09 1993-05-05 Hoechst Aktiengesellschaft Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non steroidal anti-flammatory drugs
FR2741534B1 (fr) * 1995-11-23 1998-09-11 Mazal Pharma Composition pharmaceutique stable a base d'acide acetylsalicylique et de tocopherol
JPH11222425A (ja) * 1997-10-27 1999-08-17 Ss Pharmaceut Co Ltd 関節疾患治療用関節内投与製剤
DE10034802A1 (de) * 2000-07-18 2002-01-31 Bayer Ag Stabile Salze von O-Acetylsalicylsäure mit basischen Aminosäuren
RU2203064C2 (ru) * 2001-03-11 2003-04-27 Каменев Виктор Федорович Способ лечения аспириновой бронхиальной астмы
DE10202019A1 (de) * 2002-01-18 2003-07-24 Bayer Ag Stabile Salze von o-Acetylsalicylsäure mit basischen Aminosäuren II
DE102004025535A1 (de) * 2004-05-25 2005-12-22 Bayer Healthcare Ag Kombination von Salzen der o-Acetylsalicylsäure und Alpha-Glucosidase-Inhibitoren

Also Published As

Publication number Publication date
KR101347522B1 (ko) 2014-01-02
RS52111B (en) 2012-08-31
TNSN07452A1 (en) 2009-03-17
AR057341A1 (es) 2007-11-28
NO20076592L (no) 2007-12-20
IL187772A (en) 2013-06-27
CN101248036A (zh) 2008-08-20
ZA200710251B (en) 2009-09-30
PT1890994E (pt) 2012-01-05
WO2006128600A2 (de) 2006-12-07
EP1890994A2 (de) 2008-02-27
SG162744A1 (en) 2010-07-29
AU2006254429B2 (en) 2011-11-10
ES2373917T3 (es) 2012-02-10
KR20080030578A (ko) 2008-04-04
TWI374740B (en) 2012-10-21
CY1112185T1 (el) 2015-12-09
BRPI0610734A2 (pt) 2010-07-20
HRP20120003T1 (hr) 2012-01-31
DK1890994T3 (da) 2012-02-06
RU2433995C2 (ru) 2011-11-20
MA29604B1 (fr) 2008-07-01
UA89827C2 (ru) 2010-03-10
JP2008542316A (ja) 2008-11-27
NZ563871A (en) 2011-02-25
CA2610194C (en) 2013-11-05
CA2610194A1 (en) 2006-12-07
DE102005025283A1 (de) 2006-12-07
US20090226524A1 (en) 2009-09-10
RU2007148709A (ru) 2009-07-20
US8063243B2 (en) 2011-11-22
ATE526974T1 (de) 2011-10-15
TW200716138A (en) 2007-05-01
MX2007014988A (es) 2008-02-15
EP1890994B1 (de) 2011-10-05
CR9556A (es) 2008-03-03
CN101248036B (zh) 2016-03-16
AU2006254429A1 (en) 2006-12-07
IL187772A0 (en) 2008-08-07
WO2006128600A3 (de) 2007-04-26
SI1890994T1 (sl) 2012-02-29

Similar Documents

Publication Publication Date Title
IL187772A0 (en) Stabile active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine
HRP20181823T1 (hr) Aminokiselinski lipidi i njihove primjene
EP2197897A4 (en) AMINO ACID MATCHING-BASED SELF-ASSEMBLY PEPTIDES AND METHODS
ZA200807074B (en) 4-phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as PLK1 inhibitors
EP2183213A4 (en) OPTICALLY ACTIVE (R) -ARYLOXYPROPIONIC ACID AMIDE AND HERBICIDES COMPOSITION CONTAINING THEREOF
EP2045253A4 (en) alpha-amino acid derivative and pharmaceutical agent containing it as an active ingredient
IL194874A0 (en) Processes for the prepartion of r-(+)-3-(carbomoyl methyl)-5-methylhexanoic acid and salts thereof
ZA200804611B (en) Methods for the use of branched chain amino acids
HUP0302053A3 (en) Stable salts of o-acetylsalicylic with basic amino acids amino acids
IL185895A0 (en) Pyrimidine carboxylic acid derivatives and use thereof
ZA200804780B (en) Preparation of gamma-amino acids having affinity for the alpha-2-delta protein
IL185790A0 (en) Amino acid derivatives
GB0624084D0 (en) Ramipril amino acid salts
ZA200803206B (en) Crystalline forms of the di-sodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid
EP1968650A4 (en) COMPOUNDS FOR DELIVERING AMINO ACIDS OR PEPTIDES WITH ANTIOXIDANT ACTIVITY IN MITOCHONDRIA AND THEIR USE
NO20043404L (no) Stabile salter med o-acetylsalisylsyre inneholdende basiske aminosyrer II
EP2231622A4 (en) AMINO ACIDS AND OROTIC ACID CONTAINING PREPARATIONS
ZA200907052B (en) Aliphatic acid-containing n-halogenated amino acid formulations
ZA200707238B (en) Preparation of optically pure beta-amino acids having affinity for the alpha-2-delta protein
ZA200801664B (en) Amino acid and its uses
HK1125032A1 (en) Uses of amino acid and amino acid supplements thereof
IL179851A0 (en) Preparation of beta-amino acids having affinity for the alpha-2-delta protein
GB0420607D0 (en) Amino acid
IL210842A (en) A single solid product containing protein, protease inhibitor and salt of nac or nad and use of this preparation for oral administration of the protein
IL216710A0 (en) Amino acid lipids and uses thereof